eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Thornton & Ross Ltd

Telephone: +44 (0)1484 842217
Fax: +44 (0)1484 847301
WWW: http://www.thorntonandross.com
Medical Information Direct Line: +44(0)1484 848 251
Medical Information e-mail: phv@thorntonross.co.uk
Customer Care direct line: +44(0)1484 842 217
Medical Information Fax: +44(0)1484 847 301

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 22/11/2011
SPC Transvasin Heat Spray


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Transvasin Heat Spray

Radian B Heat Spray


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

2-Hydroxyethyl Salicylate 5% w/w

Diethylamine Salicylate 5% w/w

Methyl Nicotinate 1% w/w

For excipients, see 6.1


Go to top of the page
3. PHARMACEUTICAL FORM

Cutaneous spray, solution (Cutaneous Spray)

A pale yellow, clear liquid.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the symptomatic relief of muscular and rheumatic pain.


Go to top of the page
4.2 Posology and method of administration

There is no difference between the dosage for adults, children or the elderly.

Shake the can well before use. Holding the can about 6 inches from the skin surface, point nozzle arrow towards painful area. Spray evenly using short bursts. There is no need to massage.


Go to top of the page
4.3 Contraindications

Do not use on children under five years of age.

The spray is for external use only.

Do not allow the spray to enter the eyes.

Do not use on skin which is inflamed or broken or where there is known hypersensitivity to salicylates or any of the other constituents of the spray.


Go to top of the page
4.4 Special warnings and precautions for use

If symptoms persist consult your doctor.

Discontinue use if excessive irritation occurs.

Avoid inhalation of the spray

Caution: The Spray is flammable. Do not use near fire or flame.

Pressurised container: Protect from sunlight and do not expose to temperatures exceeding 50°C.

Keep away from the eyes, nose and other sensitive areas.

Do not pierce or burn the can, even after use.

Do not spray on a naked flame or any incandescent material.

Do not use near, and do not place the container on, polished or painted surfaces.

Keep out of the reach and sight of children.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

As with all medicinal compounds care should be taken when administering the product to pregnant or lactating women.


Go to top of the page
4.7 Effects on ability to drive and use machines

No or negligible influence.


Go to top of the page
4.8 Undesirable effects

After application a slight transient erythema may develop.

Contact dermatitis has been reported for hydroxyethyl salicylate.


Go to top of the page
4.9 Overdose

Overdose is unlikely when applied externally. Ingestion of very large amounts may result in symptoms of salicylate toxicity e.g. dizziness, tinnitus, deafness, nausea, vomiting, headache and mental confusion.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

M02A C Topical products for joint and muscular pain. Preparations with salicylic acid derivatives.

The active ingredients are commonly found in topical analgesic and rubefacient preparations. 2-Hydroxyethyl Salicylate is a rubefacient as is Methyl Nicotinate and Diethylamine Salicylate is a topical analgesic for rheumatic and muscular pain.


Go to top of the page
5.2 Pharmacokinetic properties

Methyl Nicotinate percutaneous absorption may occur dependent on the vehicle base and is via the intercellular route. There is no evidence to suggest that percutaneous absorption of the other constituents occurs to any great extent.


Go to top of the page
5.3 Preclinical safety data

Not applicable


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Isopropyl Alcohol

Butane Propellant


Go to top of the page
6.2 Incompatibilities

None known


Go to top of the page
6.3 Shelf life

36 months.


Go to top of the page
6.4 Special precautions for storage

Protect from sunlight and do not expose to temperatures exceeding 50°C.


Go to top of the page
6.5 Nature and contents of container

Internally lacquered, three piece, tin plate aerosol can containing 125ml or 150ml of product with a standard aerosol valve and high density polyethylene cap.


Go to top of the page
6.6 Special precautions for disposal and other handling

None stated


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Thornton & Ross Limited

Linthwaite

Huddersfield

West Yorkshire

HD7 5QH

United Kingdom


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 00240/0070


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

6 September 2002


Go to top of the page
10. DATE OF REVISION OF THE TEXT

27/01/2011



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/25403/SPC/


Active Ingredients/Generics

 
   diethylamine salicylate
   methyl nicotinate
   2-hydroxyethyl salicylate